Trial Profile
Detection rate of 68Ga-PSMA PET/CT for metastatic disease prostate cancer in patients with biochemical recurrence.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jul 2016
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 05 Jul 2016 New trial record